No Data
No Data
Zhiyun Health (09955): Unusual share price and trading volume fluctuations The management team is still confident about the company's long-term prospects
Zhitong Finance App News, Zhiyun Health (09955) announced that the company's shares have recently experienced a drop in transaction price and an increase in trading volume. After making all reasonable enquiries about the Company's circumstances, the Board confirmed that it was unaware of any reason for the recent fluctuations in transaction prices and volume, or any information that must be published to avoid causing a false market in the Company's securities, or any insider information required to be disclosed in accordance with Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). The board of directors confirmed that the company's business operations are in good condition and that the management team has maintained a long-term relationship with the company
Zhiyun Health (09955.HK): Loss reduction exceeds expectations, exploring a new P2M model
Revenue for 2023 fell short of our expectations, and the loss margin was less than our expectations, Zhiyun Health announced 2023 results: Revenue increased 23.5% year-on-year to 3.69 billion yuan, lower than our previous expectations, mainly due to quasi-marketing and pharmacy solutions
Changes in Hong Kong stocks | Zhiyun Health (09955) rose more than 7% in 23 years, the company's revenue maintained rapid growth and turned a loss into a profit in the fourth quarter
The Zhitong Finance App learned that Zhiyun Health (09955) rose by more than 7% and rose 7.19% at press time to HK$3.13, with a turnover of HK$21.77 million. According to the news, on March 21, financial reports showed that in 2023, Zhiyun Health's revenue continued to grow rapidly, with revenue reaching 3.69 billion yuan, an increase of 23.5% over the previous year. Non-IFRS (non-IFRS) adjusted net loss narrowed to 75.1 million yuan, a year-on-year decrease of 77.4%. The fourth quarter became the company's first profitable quarter, turning losses into profits in a single quarter. Financial reports show that Zhiyun Health's three major business boards
ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%
ClouDr Group (HKG:9955) narrowed its net loss by 80.7% to 327.34 million yuan in the year ended Dec. 31, 2023, against 1.69 billion yuan a year ago, according to a Thursday filing with the Hong Kong S
Zhiyun Health (09955) Digitalization empowers pharmacy operations to improve quality and efficiency
More than 200,000 pharmacies across the country have installed the Zhiyun Health Pharmacy SaaS system. The Zhiyun Health Out-of-Hospital platform links upstream and downstream partners outside the hospital, carries services and products, and relies on a strong central platform to support the efficient operation of out-of-hospital business.
The rapid development of “Internet+Healthcare” Zhiyun Health (09955)'s revenue in 2023 increased 23.5% year-on-year to 3.69 billion yuan
Zhiyun Health (09955) announced its annual results for the year ended December 31, 2023, with group revenue of RMB 36...
No Data